Claire Taylor
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 5
- Molecular Biology top 10%
- Epigenetics and DNA Methylation 6
- Fibroblast Growth Factor Research 2
- Molecular Biology Techniques and Applications 2
- PI3K/AKT/mTOR signaling in cancer 2
- RNA modifications and cancer 2
- Oncology top 10%
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments 5
-
- Renal cell carcinoma treatment 2
- Co-authors
- Margaret A. KnowlesCarolyn D. HurstPatricia HarndenFiona M. PlattAdel JebarC.F. JohnstonDarren C. TomlinsonWalter M. Gregory
- Journals
- Proceedings of the National Academy of Sciences (1 paper)PLoS ONE (2 papers)Cancer Research (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Claire Taylor
19 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 321
- Molecular Biology 953
- Oncology 266
- Surgery 388
- Pulmonary and Respiratory Medicine 282
Countries citing papers authored by Claire Taylor
This map shows the geographic impact of Claire Taylor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Taylor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Taylor more than expected).
Fields of papers citing papers by Claire Taylor
This network shows the impact of papers produced by Claire Taylor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Taylor. The network helps show where Claire Taylor may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Claire Taylor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 4 | |
| 2 | 2019 | 28 | |
| 3 | 2015 | 1 | |
| 4 | 2013 | 72 | |
| 5 | 2013 | 13 | |
| 6 | 2013 | 26 | |
| 7 | 2013 | 13 | |
| 8 | 2012 | 11 | |
| 9 | 2011 | 8 | |
| 10 | 2009 | 202 | |
| 11 | 2009 | 84 | |
| 12 | 2006 | 214 | |
| 13 | 2005 | 27 | |
| 14 | 2005 | 52 | |
| 15 | 2005 | 265 | |
| 16 | 2005 | 29 | |
| 17 | 2004 | 14 | |
| 18 | 2004 | 63 | |
| 19 | 2001 | 197 |
About Claire Taylor
Claire Taylor is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 19 papers that have together received 1.3k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (6 papers), Bladder and Urothelial Cancer Treatments (5 papers), Cancer Genomics and Diagnostics (5 papers), Renal cell carcinoma treatment (2 papers), Fibroblast Growth Factor Research (2 papers), Molecular Biology Techniques and Applications (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (321 citations), Molecular Biology (953 citations) and Oncology (266 citations). Claire Taylor has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Margaret A. Knowles, Carolyn D. Hurst, Patricia Harnden, Fiona M. Platt, Adel Jebar, C.F. Johnston, Darren C. Tomlinson, Walter M. Gregory, Karen J. Taylor and David J. Porteous. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.